Corbus Pharmaceuticals
CRBP
CRBP
77 hedge funds and large institutions have $166M invested in Corbus Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 22 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
0.14% less ownership
Funds ownership: 1.42% → 1.28% (-0.14%)
6% less funds holding
Funds holding: 82 → 77 (-5)
29% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 17
Holders
77
Holding in Top 10
1
Calls
$3.64M
Puts
$2.86M
Top Buyers
| 1 | +$9.49M | |
| 2 | +$2.27M | |
| 3 | +$1.97M | |
| 4 |
Morgan Stanley
New York
|
+$1.33M |
| 5 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$1.12M |
Top Sellers
| 1 | -$16.3M | |
| 2 | -$1.25M | |
| 3 | -$927K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$923K |
| 5 |
Renaissance Technologies
New York
|
-$842K |